Open Access 19.07.2021 | Correction
Correction to: Safety and Effectiveness of Ipragliflozin for Type 2 Diabetes in Japan: 12-Month Interim Results of the STELLA-LONG TERM Post-Marketing Surveillance Study
Erschienen in: Advances in Therapy | Ausgabe 8/2021
Einloggen, um Zugang zu erhalten